Jay A. Levy

29.6k total citations · 7 hit papers
306 papers, 22.8k citations indexed

About

Jay A. Levy is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Jay A. Levy has authored 306 papers receiving a total of 22.8k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Virology, 131 papers in Immunology and 120 papers in Infectious Diseases. Recurrent topics in Jay A. Levy's work include HIV Research and Treatment (192 papers), Immune Cell Function and Interaction (81 papers) and HIV/AIDS Research and Interventions (62 papers). Jay A. Levy is often cited by papers focused on HIV Research and Treatment (192 papers), Immune Cell Function and Interaction (81 papers) and HIV/AIDS Research and Interventions (62 papers). Jay A. Levy collaborates with scholars based in United States, Japan and United Kingdom. Jay A. Levy's co-authors include Cecilia Cheng‐Mayer, Christopher M. Walker, Carl E. Mackewicz, Anthony Hoffman, Daniel P. Stites, Paul A. Luciw, David J. Blackbourn, Dewey J. Moody, Lyndon S. Oshiro and Masatoshi Tateno and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Jay A. Levy

303 papers receiving 21.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS

1984 1.1k citations Jay A. Levy et al. Science profile →
CD8 ⁺ Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus Replication

1986 838 citations Jay A. Levy et al. Science profile →
Pathogenesis of human immunodeficiency virus infection

1993 708 citations Jay A. Levy profile →
Nucleotide Sequence and Expression of an AIDS-Associated Retrovirus (ARV-2)

1985 629 citations Jay A. Levy et al. Science profile →
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load

2004 605 citations Jay A. Levy, Frederick Hecht et al. profile →
Biologic Features of HIV-1 That Correlate with Virulence in the Host

1988 591 citations Cecilia Cheng‐Mayer, Jay A. Levy et al. Science profile →
Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp!20 gene

1991 467 citations Tatsuo Shioda, Jay A. Levy et al. Nature profile →

Peers

Countries citing papers authored by Jay A. Levy

Since Specialization

Citations

This map shows the geographic impact of Jay A. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay A. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay A. Levy more than expected).

Fields of papers citing papers by Jay A. Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay A. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay A. Levy. The network helps show where Jay A. Levy may publish in the future.

Co-authorship network of co-authors of Jay A. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Jay A. Levy. A scholar is included among the top collaborators of Jay A. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay A. Levy. Jay A. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection 2014 ·Proceedings of the National Academy of Sciences ·Lin Ye, Jiaming Wang, Ashley I. Beyer, Fernando Teque, Thomas J. Cradick, Zhongxia Qi, Judy C. Chang, Gang Bao, Marcus O. Muench, Jingwei Yu, Jay A. Levy, Yuet Wai Kan	247
2	Plasmacytoid Dendritic Cell Number and Responses to Toll-Like Receptor 7 and 9 Agonists Vary in HIV Type 1-Infected Individuals in Relation to Clinical State 2012 ·AIDS Research and Human Retroviruses ·Shweta Kaushik, Fernando Teque, Mira C. Patel, Sue H. Fujimura, Bárbara Schmidt, Jay A. Levy	20
3	No Evidence of Murine-Like Gammaretroviruses in CFS Patients Previously Identified as XMRV-Infected 2011 ·Science ·Konstance Knox, Donald R. Carrigan, Graham Simmons, Fernando Teque, Yanchen Zhou, John Hackett, Xiaoxing Qiu, Ka‐Cheung Luk, Gerald Schochetman, (unknown), Andreas M. Kogelnik, Jay A. Levy	87
4	Selection of conserved HIV-1 vaccine epitopes based on cross-reactivity to feline immunodeficiency virus (53.17) 2011 ·The Journal of Immunology ·(unknown), James Coleman, Jay A. Levy, Janet K. Yamamoto	1
5	HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells 2010 ·Virology ·Sharof M. Tugizov, Rossana Herrera, (unknown), Deborah Greenspan, Vanessa B. Soros, Warner C. Greene, Jay A. Levy, Joel M. Palefsky	56
6	Derivation of infectious HIV-1 molecular clones with LTR mutations: Sensitivity to the CD8+ cell noncytotoxic anti-HIV response 2007 ·Virology ·Kyle Bonneau, (unknown), (unknown), (unknown), Ben Berkhout, Arnold B. Rabson, Carl E. Mackewicz, Jay A. Levy	8
7	The Effects of Early Antiretroviral Therapy and Its Discontinuation on the HIV-Specific Antibody Response 2006 ·AIDS Research and Human Retroviruses ·M. Scott Killian, Philip J. Norris, B. D. Rawal, Mila Lebedeva, Frederick Hecht, Jay A. Levy, Michael P. Busch	38
8	Potential Herpesvirus Interaction during HIV Type 1 Primary Infection 2005 ·AIDS Research and Human Retroviruses ·Evelyne T. Lennette, Michael P. Busch, Frederick Hecht, Jay A. Levy	9
9	VCAM-1 Expression on CD8+ Cells Correlates with Enhanced Anti-HIV Suppressing Activity 2005 ·The Journal of Immunology ·(unknown), (unknown), (unknown), Sue H. Fujimura, David A. Relman, Jay A. Levy	11
10	Evaluation of Genetic Immunization Adjuvants to Improve the Effectiveness of a Human Immunodeficiency Virus Type 2 (HIV-2) Envelope DNA Vaccine 2004 ·DNA and Cell Biology ·Christopher P. Locher, (unknown), Brittany M. Ashlock, Jay A. Levy	15
11	Expression Patterns of Phenotypic Markers on Lymphocytes from Human Immunodeficiency Virus Type 2-Infected Baboons 2003 ·AIDS Research and Human Retroviruses ·Christopher P. Locher, Sue H. Fujimura, Krishna K. Murthy, Kathleen M. Brasky, M. Michelle Leland, Jay A. Levy	2
12	Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection 2003 ·Vaccine ·Christopher P. Locher, (unknown), Brittany M. Ashlock, Patricia Polacino, (unknown), Stephen Shiboski, Ann Marie Schmidt, Michael B. Agy, David Anderson, Silvija I. Staprans, Jan zur Megede, Jay A. Levy	19
13	Enhancement of Antibody Responses to an HIV-2 DNA Envelope Vaccine Using an Expression Vector Containing a Constitutive Transport Element 2002 ·DNA and Cell Biology ·Christopher P. Locher, (unknown), Brittany M. Ashlock, Jay A. Levy	6
14	Genetic Analysis of Viral Variants Selected in Transmission of Human Immunodeficiency Viruses to Newborns 2000 ·AIDS Research and Human Retroviruses ·Srisakul Kliks, Christopher H. Contag, (unknown), Gerald H. Learn, Allen G. Rodrigo, Diane W. Wara, James I. Mullins, Jay A. Levy	26
15	Biological, Serological, and Genetic Characterization of HIV-1 Subtype E Isolates from Northern Thailand 1994 ·AIDS Research and Human Retroviruses ·Hiroshi Ichimura, Srisakul Kliks, (unknown), Chin‐Yih Ou, Marcia L. Kalish, Jay A. Levy	39
16	An Anti-gp41 Human Monoclonal Antibody That Enhances HIV-1 Infection in the Absence of Complement 1994 ·AIDS Research and Human Retroviruses ·(unknown), Kenneth E. Ugen, D B Weiner, (unknown), Jay A. Levy	21
17	Prevalence of HTLV Infection in the Dominican Republic: Association with Neurological Disease 1992 ·AIDS Research and Human Retroviruses ·Robert Koenig, (unknown), Luis R. Taveras, Frank Ferro, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mark Connelly, Jay A. Levy	14
18	CD8 ⁺ Cell Anti-HIV Activity: Nonlytic Suppression of Virus Replication 1992 ·AIDS Research and Human Retroviruses ·Carl E. Mackewicz, Jay A. Levy	159
19	Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp!20 gene breakdown → 1991 ·Nature ·Tatsuo Shioda, Jay A. Levy, Cecilia Cheng‐Mayer	467
20	ANTIBODIES TO THE AIDS-ASSOCIATED RETROVIRUS IN HEMOPHILIACS AND OTHER INDIVIDUALS FROM SOUTHERN SPAIN: LACK OF CORRELATION WITH LYMPHOCYTES SUB-POPULATIONS 1983 ·PubMed ·(unknown), M Leal, I. Wichmann, E Lissén, Jay A. Levy	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact